vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $41.3M, roughly 1.2× Northfield Bancorp, Inc.). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -1545.5%, a 1540.7% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $52.5M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
IRWD vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $41.3M |
| Net Profit | $-2.3M | $-27.4M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -1263.3% |
| Net Margin | -4.8% | -1545.5% |
| Revenue YoY | -47.3% | 12.7% |
| Net Profit YoY | -200.9% | -343.6% |
| EPS (diluted) | $0.01 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $41.3M | ||
| Q3 25 | $122.1M | $39.2M | ||
| Q2 25 | $85.2M | $38.9M | ||
| Q1 25 | $41.1M | $34.8M | ||
| Q4 24 | $90.5M | $36.7M | ||
| Q3 24 | $91.6M | $31.8M | ||
| Q2 24 | $94.4M | $31.5M | ||
| Q1 24 | $74.9M | $31.3M |
| Q4 25 | $-2.3M | $-27.4M | ||
| Q3 25 | $40.1M | $10.8M | ||
| Q2 25 | $23.6M | $9.6M | ||
| Q1 25 | $-37.4M | $7.9M | ||
| Q4 24 | $2.3M | $11.3M | ||
| Q3 24 | $3.6M | $6.5M | ||
| Q2 24 | $-860.0K | $6.0M | ||
| Q1 24 | $-4.2M | $6.2M |
| Q4 25 | 14.3% | -1263.3% | ||
| Q3 25 | 61.8% | 37.7% | ||
| Q2 25 | 53.2% | 35.6% | ||
| Q1 25 | -70.7% | 31.0% | ||
| Q4 24 | 34.8% | 38.0% | ||
| Q3 24 | 28.0% | 27.9% | ||
| Q2 24 | 26.5% | 29.1% | ||
| Q1 24 | 14.7% | 27.2% |
| Q4 25 | -4.8% | -1545.5% | ||
| Q3 25 | 32.8% | 27.4% | ||
| Q2 25 | 27.7% | 24.6% | ||
| Q1 25 | -90.9% | 22.6% | ||
| Q4 24 | 2.5% | 30.7% | ||
| Q3 24 | 4.0% | 20.5% | ||
| Q2 24 | -0.9% | 18.9% | ||
| Q1 24 | -5.6% | 19.9% |
| Q4 25 | $0.01 | $-0.68 | ||
| Q3 25 | $0.23 | $0.27 | ||
| Q2 25 | $0.14 | $0.24 | ||
| Q1 25 | $-0.23 | $0.19 | ||
| Q4 24 | $0.03 | $0.27 | ||
| Q3 24 | $0.02 | $0.16 | ||
| Q2 24 | $-0.01 | $0.14 | ||
| Q1 24 | $-0.03 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $690.1M |
| Total Assets | $396.9M | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $164.0M | ||
| Q3 25 | $140.4M | $131.7M | ||
| Q2 25 | $92.9M | $97.6M | ||
| Q1 25 | $108.5M | $101.7M | ||
| Q4 24 | $88.6M | $167.7M | ||
| Q3 24 | $88.2M | $232.9M | ||
| Q2 24 | $105.5M | $153.5M | ||
| Q1 24 | $121.5M | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $666.4M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $690.1M | ||
| Q3 25 | $-264.2M | $719.6M | ||
| Q2 25 | $-308.2M | $710.3M | ||
| Q1 25 | $-334.1M | $711.1M | ||
| Q4 24 | $-301.3M | $704.7M | ||
| Q3 24 | $-311.3M | $699.6M | ||
| Q2 24 | $-321.7M | $693.0M | ||
| Q1 24 | $-330.5M | $698.4M |
| Q4 25 | $396.9M | $5.8B | ||
| Q3 25 | $396.1M | $5.7B | ||
| Q2 25 | $342.9M | $5.7B | ||
| Q1 25 | $327.2M | $5.7B | ||
| Q4 24 | $350.9M | $5.7B | ||
| Q3 24 | $389.5M | $5.7B | ||
| Q2 24 | $395.6M | $5.7B | ||
| Q1 24 | $438.8M | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $53.7M |
| Free Cash FlowOCF − Capex | $74.6M | $52.5M |
| FCF MarginFCF / Revenue | 156.3% | 127.1% |
| Capex IntensityCapex / Revenue | 0.0% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $53.7M | ||
| Q3 25 | $47.6M | $13.9M | ||
| Q2 25 | $-15.1M | $14.1M | ||
| Q1 25 | $20.0M | $9.4M | ||
| Q4 24 | $15.2M | $31.1M | ||
| Q3 24 | $9.9M | $14.0M | ||
| Q2 24 | $33.5M | $6.9M | ||
| Q1 24 | $45.0M | $4.2M |
| Q4 25 | $74.6M | $52.5M | ||
| Q3 25 | $47.6M | $13.6M | ||
| Q2 25 | $-15.1M | $13.9M | ||
| Q1 25 | $19.9M | $9.2M | ||
| Q4 24 | — | $30.0M | ||
| Q3 24 | $9.9M | $13.7M | ||
| Q2 24 | $33.4M | $6.7M | ||
| Q1 24 | $44.9M | $3.8M |
| Q4 25 | 156.3% | 127.1% | ||
| Q3 25 | 39.0% | 34.6% | ||
| Q2 25 | -17.7% | 35.7% | ||
| Q1 25 | 48.4% | 26.3% | ||
| Q4 24 | — | 81.6% | ||
| Q3 24 | 10.8% | 43.2% | ||
| Q2 24 | 35.4% | 21.1% | ||
| Q1 24 | 60.0% | 12.1% |
| Q4 25 | 0.0% | 2.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.1% | 0.8% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 1.29× | ||
| Q2 25 | -0.64× | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | 6.74× | 2.76× | ||
| Q3 24 | 2.71× | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
